Alle Storys
Folgen
Keine Story von Korian Deutschland AG mehr verpassen.

Korian Deutschland AG

EANS-Adhoc: CURANUM AG
Publishing the figures Q3/ 2010

  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
9-month report/Publishing the figures Q3/ 2010
10.11.2010
Ad hoc
|                            |         |         |         |         |         |
|                            |         |         |         |         |         |
|THE GROUP AT A GLANCE       |         |         |         |         |         |
|as of September 30, 2010    |         |         |         |         |         |
|(IFRS)                      |         |         |         |         |         |
|                            |         |         |         |         |         |
|                            |         |         |         |         |         |
|                            |         |         |         |         |         |
|in mil. Euro                |Q3/2010  |Q3/2009  |9M/2010  |9M/2009  |2009     |
|                            |         |         |         |         |         |
|Revenue                     |66.8     |65.7     |195.9    |193.1    |259.5    |
|Personnel expenditure       |34.0     |32.7     |100.2    |97.5     |130.5    |
|EBITDAR                     |21.2     |21.3     |60.7     |61.8     |83.1     |
|Rental expense              |13.8     |13.8     |41.5     |41.6     |55.5     |
|EBITDA                      |7.4      |7.5      |19.2     |20.1     |27.6     |
|as % of revenue             |11.1%    |11.4%    |9.8%     |10.4%    |10.6%    |
|Depreciation / amortization |2.7      |2.5      |7.6      |7.3      |9.8      |
|EBIT                        |4.7      |5.0      |11.6     |12.8     |17.8     |
|as % of revenue             |7.0%     |7.6%     |5.9%     |6.6%     |6.9%     |
|Net financial result        |-2.5     |-2.3     |-7.3     |-6.7     |-8.9     |
|EBT                         |2.2      |2.7      |4.3      |6.1      |8.9      |
|Net profit                  |1.4      |2.0      |1.4      |4.2      |5.8      |
|EPS (Euro)*                 |0.04     |0.06     |0.04     |0.13     |0.18     |
|                            |         |         |         |         |         |
|Cash Flow                   |14.8     |5.4      |25.4     |14.1     |19.9     |
|CPS (Euro)**                |0.46     |0.17     |0.79     |0.44     |0.62     |
|                            |         |         |         |         |         |
|Cash and cash equivalents   |24.4     |7.6      |24.4     |7.6      |8.9      |
|Equity                      |67.3     |64.3     |67.3     |64.3     |66.1     |
|as % of total equity and    |25.1%    |27.2%    |25.1%    |27.2%    |28.0%    |
|liabilities                 |         |         |         |         |         |
|Total assets                |268.3    |236.8    |268.3    |236.8    |236.4    |
|                            |         |         |         |         |         |
|Employees                   |6,275    |6,091    |6,202    |6,056    |6,055    |
|Facilities                  |70       |69       |70       |69       |69       |
|Care places                 |7,867    |7,805    |7,867    |7,805    |7,805    |
|Assisted living apartments  |1,679    |1,681    |1,679    |1,681    |1,681    |
|                            |         |         |         |         |         |
|                            |         |         |         |         |         |
|                            |         |         |         |         |         |
|                            |         |         |         |         |         |
| *) Number of underlying outstanding shares in Q3/2010:    |         |
|
|32,267,835 shares                                          |         |
|
| *) Number of underlying outstanding shares in Q3/2009:    |         |
|
|32,254,898 shares                                          |         |
|
| *) Number of underlying outstanding shares in 9M/2010:    |         |
|
|32,267,835 shares                                          |         |
|
| *) Number of underlying outstanding shares in 9M/2009:    |         |
|
|32,289,742 shares                                          |         |
|
|**) Cash Flow from operating activities Number of          |         |
|
|dividend-entitled shares                                   |         |
|
Third-quarter revenue was up by 1.7% year-on-year (Euro 1.1  million)  to  reach
Euro 66.8 million. This increase was mainly due to the start-up  of  care  homes
in Braunschweig and Wachtendonk. Capacity at existing  Curanum  facilities  also
reported a pleasing trend in the third quarter,  reaching  the  previous  year's
level.
The personnel expense increased at a disproportionately faster rate of 4%  (Euro
1.3  million)  in  the  third  quarter,  to  a  level  of  Euro  34.0   million.
Correspondingly, the personnel cost ratio was up by  1.1  percentage  points  to
50.9%. The increase was primarily due to the start-up of the new  facilities  in
Braunschweig and Wachtendonk, as well as to a slight increase in the  proportion
of temporary help work. The introduction of  the  statutory  minimum  wage,  and
restructuring-related special effects, also burdened this item.
The third-quarter rental expense of  Euro  13.8  million  was  at  the  previous
year's level. This is mainly due to relief effects arising  from  the  sale-and-
lease-back concept for our home in Greiz and a new finance lease  contract  four
our home Geseke, as well as burdening effects arising from contractually  agreed
rental adjustments for some homes.
 
Consequently,  operating  EBITDA  earnings,  in  other  words,  earnings  before
interest, tax, depreciation and amortization, were almost unchanged at Euro  7.4
million, allowing the second quarter's falling earnings trend to be reduced.
The post-tax result amounted to Euro 1.4 million in the third quarter, Euro  0.6
million below the previous year's level. Earnings per  share  amounted  to  Euro
0.04 as a consequence. Earnings  after  tax  reached  Euro  1.4  million  as  of
September, which also corresponds to earnings per share of
Euro 0.04.
The Group's total assets at the end of the third quarter increased by Euro  31.9
million, or 13.5% compared with the start of  the  year,  to  reach  Euro  268.3
million.
Property, plant and equipment rose by Euro 18.6 million to Euro  214.4  million.
This is mainly due to the capitalization of our  new  facility  in  Wachtendonk,
new finance lease contracts for Geseke and Greiz  and  investments  in  existing
facilities and the laundry.
The cash flow of  the  Curanum  Group  amounted  to  Euro  15.5  
million  as  of September 2010. It consists of cash flow from 
operating activities of Euro  25.4 million (previous year: Euro 14.1 
million), cash flow from investing  activities of Euro 0.2 million 
(previous year: Euro  -3.7  million),  and  cash  flow  from 
financing activities of Euro -10.1 million (previous year: Euro -12.8
million).
Munich, November 2010
The Management Board
end of announcement                               euro adhoc

Further inquiry note:

Bettina Pöschl, Marketing
Tel. +49(0)89-242065-69
E-Mail: bettina.poeschl@curanum.de

Branche: Healthcare Providers
ISIN: DE0005240709
WKN: 524070
Index: CDAX, Classic All Share, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / regulated dealing

Weitere Storys: Korian Deutschland AG
Weitere Storys: Korian Deutschland AG
  • 28.09.2010 – 14:23

    EANS-News: CURANUM AG / Walther Wever appointed management board chairman of CURANUM AG

    Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. Personnel/New Chairman of CURANUM AG München (euro adhoc) - Press release Walther Wever appointed management board chairman of CURANUM AG In its meeting today, the supervisory board of CURANUM AG, Munich, one of the largest private ...

  • 28.09.2010 – 13:37

    EANS-Adhoc: CURANUM AG / Walther Wever appointed new chairman of the CURANUM AG management board

    ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information/New chairman of the CURANUM AG 28.09.2010 Ad hoc announcement Walther Wever appointed new chairman of the CURANUM AG management board In its ...

  • 03.09.2010 – 12:24

    EANS-Adhoc: CURANUM AG / Changes to the Chairmanship of the Management Board of CURANUM AG

    ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Company Information/Changes to the Chairmanship of the Management Board of CURANUM AG 03.09.2010 Unscheduled announcement Changes to the Chairmanship of the ...